Clinical Trial Update: Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nalmefene for alcohol dependence in patients with compensated alcoholic cirrhosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Cirrhosis

Drugs mentioned

• Nalmefene (nalmefene)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Cirrhosis, Alcohol Dependence | Phase 3 | Status: WITHDRAWN